Attached files
| file | filename |
|---|---|
| S-1/A - FORM S-1/A - Nascent Biotech Inc. | nbio_s1a.htm |
| EX-23.2 - CONSENT - Nascent Biotech Inc. | nbio_ex232.htm |
| EX-10.4 - STOCK PURCHASE AGREEMENT - Nascent Biotech Inc. | nbio_ex104.htm |
| EX-5.1 - OPINION - Nascent Biotech Inc. | nbio_ex51.htm |
| EX-3.1 - CERTIFICATE OF DESIGNATION - Nascent Biotech Inc. | nbio_ex31.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement on Form S-1 of our report dated July 12, 2019 with respect to the audited consolidated financial statements of Nascent Biotech, Inc. (the “Company”) for the year ended March 31, 2019. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the references to us under the heading “Experts” in such Registration Statement.
/s/ MaloneBailey, LLP
www.malonebailey.com
Houston, Texas
December 18, 2020
